| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 电解质类药物(元) | 90,719,891.70 | 124,180,591.85 | 68,000,015.11 | 235,658,126.11 | 120,965,254.28 |
| 骨科药物(元) | 117,878,205.79 | 271,532,475.64 | 137,876,458.63 | 270,398,757.52 | 149,945,470.09 |
| 抗肝炎药物(元) | - | - | - | 25,242,639.57 | 12,069,993.77 |
| 抗感染药物(元) | 17,361,370.74 | 51,035,223.15 | 21,318,781.27 | 63,406,768.44 | 32,152,550.71 |
| 抗肿瘤药物(元) | 41,640,390.27 | 128,810,627.71 | 73,213,260.12 | 177,037,197.40 | 87,763,285.40 |
| 免疫增强药物(元) | - | - | - | - | 943,396.22 |
| 肾病用药(元) | - | 15,948,437.56 | 7,761,491.02 | 21,061,234.89 | 15,038,766.25 |
| 消化系统药物(元) | - | 9,924,575.00 | 6,727,325.93 | 34,028,684.37 | 18,395,469.42 |
| 心脑血管药物(元) | 307,805,064.71 | 669,503,324.71 | 356,430,709.20 | 679,825,705.33 | 360,182,739.98 |
| 血液系统药物(元) | - | - | - | 5,840,867.86 | 3,587,024.33 |
| 营养类药物(元) | - | - | - | 1,084,405,601.17 | 620,360,227.63 |
| 维生素类药物(元) | 482,478,629.29 | 1,125,237,416.07 | 531,923,340.41 | - | - |
| 其他(元) | - | - | - | 7,800,205.53 | 4,454,599.60 |
| 其他用药领域(元) | 39,157,308.68 | 39,535,509.88 | 15,555,053.51 | 21,333,518.52 | 6,804,422.80 |
| 营业成本(元) | |||||
| 电解质类药物(元) | 48,890,685.45 | 52,513,270.50 | - | 91,812,609.51 | - |
| 骨科药物(元) | 20,611,642.00 | 47,151,712.62 | 25,275,158.35 | 45,471,518.83 | 23,569,479.29 |
| 抗肝炎药物(元) | - | - | - | 7,177,887.91 | - |
| 抗感染药物(元) | 9,730,798.40 | 38,870,015.73 | - | 54,189,230.94 | - |
| 抗肿瘤药物(元) | 8,231,471.31 | 25,824,659.60 | - | 30,391,090.32 | - |
| 免疫增强药物(元) | - | - | - | - | - |
| 肾病用药(元) | - | 12,452,447.72 | - | 15,291,522.48 | - |
| 消化系统药物(元) | - | 5,503,482.27 | - | 8,136,732.99 | - |
| 心脑血管药物(元) | 165,798,793.37 | 329,974,903.07 | 179,190,383.53 | 343,697,208.06 | 152,998,804.37 |
| 血液系统药物(元) | - | - | - | 3,529,623.68 | - |
| 营养类药物(元) | - | - | - | 484,740,954.39 | 20,260,895.93 |
| 维生素类药物(元) | 302,525,345.72 | 601,897,821.95 | 273,909,007.81 | - | - |
| 其他(元) | - | - | - | 1,999,661.00 | - |
| 其他用药领域(元) | 22,894,708.78 | 19,989,003.72 | - | 6,273,043.27 | - |
| 毛利(元) | |||||
| 电解质类药物(元) | 41,829,206.25 | 71,667,321.35 | - | 143,845,516.60 | - |
| 骨科药物(元) | 97,266,563.79 | 224,380,763.02 | 112,601,300.28 | 224,927,238.69 | 126,375,990.80 |
| 抗肝炎药物(元) | - | - | - | 18,064,751.66 | - |
| 抗感染药物(元) | 7,630,572.34 | 12,165,207.42 | - | 9,217,537.50 | - |
| 抗肿瘤药物(元) | 33,408,918.96 | 102,985,968.11 | - | 146,646,107.08 | - |
| 免疫增强药物(元) | - | - | - | - | - |
| 肾病用药(元) | - | 3,495,989.84 | - | 5,769,712.41 | - |
| 消化系统药物(元) | - | 4,421,092.73 | - | 25,891,951.38 | - |
| 心脑血管药物(元) | 142,006,271.34 | 339,528,421.64 | 177,240,325.67 | 336,128,497.27 | 207,183,935.61 |
| 血液系统药物(元) | - | - | - | 2,311,244.18 | - |
| 营养类药物(元) | - | - | - | 599,664,646.78 | 600,099,331.70 |
| 维生素类药物(元) | 179,953,283.57 | 523,339,594.12 | 258,014,332.60 | - | - |
| 其他(元) | - | - | - | 5,800,544.53 | - |
| 其他用药领域(元) | 16,262,599.90 | 19,546,506.16 | - | 15,060,475.25 | - |
| 毛利率(%) | |||||
| 电解质类药物(%) | 46.11 | 57.71 | - | 61.04 | - |
| 骨科药物(%) | 82.51 | 82.63 | 81.67 | 83.18 | 84.28 |
| 抗肝炎药物(%) | - | - | - | 71.56 | - |
| 抗感染药物(%) | 43.95 | 23.84 | - | 14.54 | - |
| 抗肿瘤药物(%) | 80.23 | 79.95 | - | 82.83 | - |
| 免疫增强药物(%) | - | - | - | - | - |
| 肾病用药(%) | - | 21.92 | - | 27.39 | - |
| 消化系统药物(%) | - | 44.55 | - | 76.09 | - |
| 心脑血管药物(%) | 46.14 | 50.71 | 49.73 | 49.44 | 57.52 |
| 血液系统药物(%) | - | - | - | 39.57 | - |
| 营养类药物(%) | - | - | - | 55.30 | 96.73 |
| 维生素类药物(%) | 37.30 | 46.51 | 48.51 | - | - |
| 其他(%) | - | - | - | 74.36 | - |
| 其他用药领域(%) | 41.53 | 49.44 | - | 70.60 | - |
| 收入构成(%) | |||||
| 电解质类药物(%) | 8.27 | 5.10 | 5.58 | 8.97 | 8.44 |
| 骨科药物(%) | 10.75 | 11.15 | 11.31 | 10.30 | 10.47 |
| 抗肝炎药物(%) | - | - | - | 0.96 | 0.84 |
| 抗感染药物(%) | 1.58 | 2.10 | 1.75 | 2.41 | 2.24 |
| 抗肿瘤药物(%) | 3.80 | 5.29 | 6.01 | 6.74 | 6.13 |
| 免疫增强药物(%) | - | - | - | - | 0.07 |
| 肾病用药(%) | - | 0.65 | 0.64 | 0.80 | 1.05 |
| 消化系统药物(%) | - | 0.41 | 0.55 | 1.30 | 1.28 |
| 心脑血管药物(%) | 28.06 | 27.49 | 29.24 | 25.89 | 25.14 |
| 血液系统药物(%) | - | - | - | 0.22 | 0.25 |
| 营养类药物(%) | - | - | - | 41.29 | 43.30 |
| 维生素类药物(%) | 43.98 | 46.20 | 43.64 | - | - |
| 其他(%) | - | - | - | 0.30 | 0.31 |
| 其他用药领域(%) | 3.57 | 1.62 | 1.28 | 0.81 | 0.47 |
| 毛利构成(%) | |||||
| 电解质类药物(%) | 8.07 | 5.51 | 0.00 | 9.38 | 0.00 |
| 骨科药物(%) | 18.76 | 17.24 | 20.55 | 14.67 | 13.54 |
| 抗肝炎药物(%) | - | - | - | 1.18 | 0.00 |
| 抗感染药物(%) | 1.47 | 0.93 | 0.00 | 0.60 | 0.00 |
| 抗肿瘤药物(%) | 6.45 | 7.91 | 0.00 | 9.56 | 0.00 |
| 免疫增强药物(%) | - | - | - | - | 0.00 |
| 肾病用药(%) | - | 0.27 | 0.00 | 0.38 | 0.00 |
| 消化系统药物(%) | - | 0.34 | 0.00 | 1.69 | 0.00 |
| 心脑血管药物(%) | 27.40 | 26.09 | 32.35 | 21.92 | 22.19 |
| 血液系统药物(%) | - | - | - | 0.15 | 0.00 |
| 营养类药物(%) | - | - | - | 39.11 | 64.27 |
| 维生素类药物(%) | 34.72 | 40.21 | 47.10 | - | - |
| 其他(%) | - | - | - | 0.38 | 0.00 |
| 其他用药领域(%) | 3.14 | 1.50 | 0.00 | 0.98 | 0.00 |